Total Voting Rights

Summary by AI BETAClose X

Aviva plc has announced that as of the close of business on 30 September 2026, the company has 3,001,454,347 ordinary shares in issue, with each share carrying one vote. The company holds no treasury shares, meaning the total number of voting rights available to shareholders is also 3,001,454,347. This figure serves as the denominator for shareholders calculating their notification requirements under the FCA's Disclosure Guidance and Transparency Rules.

Disclaimer*

Aviva PLC
01 October 2026
 

 

 

 

 



01 October 2026

Aviva plc 

Total Voting Rights

 

In accordance with the Financial Conduct Authority’s (FCA) Disclosure, Guidance, and Transparency Rules (DTR) Rule 5.6.1, Aviva plc (the Company) confirms that as of close of business on 30 September 2026, being the last trading day of that month, the Company had 3,001,454,347 ordinary shares in issue of 32 17/19 pence each admitted to trading (Ordinary Shares). Each Ordinary Share carries the right to one vote in relation to all circumstances at general meetings of the Company. The Company does not hold any Ordinary Shares in treasury as at the date of this disclosure.

 

Therefore, as at close of business on 30 September 2026, the total number of voting rights in the Company was 3,001,454,347.

 

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the FCA’s DTRs.

 

-ends-

 

LEI: YF0Y5B0IB8SM0ZFG9G81

 

Enquiries:

 

Media:

 

Andrew Reid

+44 (0)7800 694 276

Sarah Swailes

Alice Constable

+44 (0)7800 694 859

+44 (0)7350 398 942

 

 

Analysts:

 

Michael O'Hara

+44 (0)7387 234 388

Joel von Sternberg

+44 (0)7384 231 238

Giles White

+44 (0)7385 011 249

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Aviva (AV.)
UK 100

Latest directors dealings